Search
Ascendis Pharma A/S
ASNDAdd to Watchlist
261.580USD
+23.570+9.90%
Close 06/25, 16:00（ET）Quotes delayed by 15 min
16.21BMarket Cap
37.69P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+9.90%
5 Days
+13.32%
1 Month
+5.88%
6 Months
+22.92%
Year to Date
+22.67%
1 Year
+51.20%
Key Figures
238.050Open
271.890High
2.65MVolume
37.69P/E TTM
22.23P/E Dynamic
--Dividend TTM
4.28%Turnover Ratio
238.010Prev. Close
235.510Low
508.16MTurnover
LossP/E Static
-83.88P/B
0.00%Div Yield TTM
32.36%ROA
250.74052wk High
3.78Volume Ratio
-378.08MNet Profit
61.98MShares
6.9400EPS TTM
0.41Beta
332.65%ROE
158.16052wk Low
15.29%Amplitude
92.90%Gross Margin
16.21BMarket Cap
0.49Reward/Risk
2.37%Risk Rate
TradingKey Stock Score of Ascendis Pharma A/S
Currency: USD Updated: 2026-06-25Key Insights
Ascendis Pharma A/S's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 6 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 299.58.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Ascendis Pharma A/S's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Ascendis Pharma A/S Highlights
StrengthsRisks
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 195.94% year-on-year.
Overvalued
The company’s latest PE is 37.69, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 69.20M shares, decreasing 2.37% quarter-over-quarter.
Held by John Hussman
Star Investor John Hussman holds 8.16K shares of this stock.
Analyst Rating
Based on
20
analysts
Strong Buy
Current Rating
299.582
Target Price
+25.56%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Ascendis Pharma A/S News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Ascendis Pharma A/S Info
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ticker SymbolASND
CompanyAscendis Pharma A/S
CEOMoller Mikkelsen (Jan)
Websitehttps://ascendispharma.dk/
Related Instruments
+1.16%
+1.66%
+1.48%
+3.67%
+4.05%
+1.27%
+0.40%
+0.44%
-1.05%
-1.48%
+1.05%
+0.75%
+1.55%
+1.14%
-0.20%
0.00%
-0.53%
+0.73%
+4.24%
-0.54%Popular Instruments
51793.400
-231.300 (-0.45%)
28912.100
-542.900 (-1.84%)
7297.800
-69.000 (-0.94%)
15112.000
-639.000 (-4.06%)
68777.000
-2355.000 (-3.31%)
6200.300
-65.500 (-1.04%)
70.498
-0.846 (-1.19%)
275.150
-17.930 (-6.12%)
195.740
-3.260 (-1.64%)
3996.200
-29.950 (-0.74%)
FAQs
What is the current price of Ascendis Pharma A/S (ASND)?
The current price of Ascendis Pharma A/S (ASND) is 261.58.
What is the symbol of Ascendis Pharma A/S?
The ticker symbol of Ascendis Pharma A/S is ASND.
What is the 52-week high of Ascendis Pharma A/S?
The 52-week high of Ascendis Pharma A/S is 250.74.
What is the 52-week low of Ascendis Pharma A/S?
The 52-week low of Ascendis Pharma A/S is 158.16.
What is the market capitalization of Ascendis Pharma A/S?
The market capitalization of Ascendis Pharma A/S is 16.21B.
Is Ascendis Pharma A/S (ASND) currently rated as Buy, Hold, or Sell?
According to analysts, Ascendis Pharma A/S (ASND) has an overall rating of STRONG BUY, with a price target of 299.58.
What is the Earnings Per Share (EPS TTM) of Ascendis Pharma A/S (ASND)?
The Earnings Per Share (EPS TTM) of Ascendis Pharma A/S (ASND) is -4.42.
